Hyunsook An
Seoul, 152703, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A novel mesenchymal epithelial transition (MET) inhibitor, CB538, relieves acquired resistance in EGFR-mutated MET-amplified non-small cell lung cancer.
Journal: Translational cancer research
Published: September 04, 2024
Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
Journal: International journal of cancer
Published: December 01, 2017
Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes stemness in mammary epithelial cells.
Journal: Cellular signalling
Published: January 09, 2017
Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis.
Journal: Biochimica et biophysica acta
Published: December 01, 2015
Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
Journal: Biochemical and biophysical research communications
Published: September 13, 2015
Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells.
Journal: PloS one
Published: April 29, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026